Piramal, Ajinomoto Partner to Boost ADC Manufacturing
MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...
September 16, 2025 — Morpeth, United Kingdom Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO),...
Piramal Pharma Solutions, a global contract development and manufacturing organization (CDMO), has collaborated with George Medicines to develop WIDAPLIKâ„¢,...
